Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;9(6):R81.
doi: 10.1186/bcr1798.

International Web-based consultation on priorities for translational breast cancer research

Affiliations

International Web-based consultation on priorities for translational breast cancer research

Mitch Dowsett et al. Breast Cancer Res. 2007.

Abstract

Background: Large numbers of translational breast cancer research topics have been completed or are underway, but they differ widely in their immediate and/or future importance to clinical management. We therefore conducted an international Web-based consultation of breast cancer professionals to identify the topics most widely considered to be of highest priority.

Methods: Potential participants were contacted via two large e-mail databases and asked to register, at a Web site, the issues that they felt to be of highest priority. Four hundred nine questions were reduced by a steering committee to 70 unique issues, and registrants were asked to select the 6 questions they considered to be the most important.

Results: Votes were recorded from 420 voters (2,520 votes) from 48 countries, with 48% of voters coming from North America. Half of the voters identified themselves as clinicians, with the remainder being academics, research scientists, or pathologists. The highest priority was to identify molecular signatures to select patients who could be spared chemotherapy, which gained about 50% more votes than the second topic and was consistently voted top by voters in North America, Europe, and the rest of the world. Research scientists voted the determination of the role of stem cells in breast cancer development, progression, and treatment sensitivity as the most important issue, but this was considered the sixth priority for clinicians and fourth overall.

Conclusion: This exercise may bring a greater focus of research resources onto issues voted as top priorities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of votes overall among the 70 questions, showing the clear distinction of the highest priority. The identities and point allotments of the questions are presented in Supplementary Table S1 (Additional Data File 1).
Figure 2
Figure 2
Distribution of votes for the top 10 topics by region of the world: (a) overall, (b) North America, (c) Europe, and (d) the rest of the world. The identity of each topic can be found by referring to the identical numbering in Table 1.
Figure 3
Figure 3
Distribution of votes for the top 10 topics by professional discipline: (a) clinicians, (b) academics, and (c) research scientists. The identity of each topic can be found by referring to the identical numbering in Table 1.

References

    1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869–10874. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
    1. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999–2009. doi: 10.1056/NEJMoa021967. - DOI - PubMed
    1. Top Ten: a global consensus http://www.toptenresearch.org
    1. Goldhirsch A, Colleoni M, Domenighetti G, Gelber RD. Systemic treatments for women with breast cancer: outcome with relation to screening for the disease. Ann Oncol. 2003;14:1212–1214. doi: 10.1093/annonc/mdg327. - DOI - PubMed
    1. Sparano JA. TAILORx: trial assigning individualized options for treatment (Rx) Clin Breast Cancer. 2006;7:347–350. - PubMed

Publication types

Substances